Bibliography for Unresectable Liver Metastases
Click either Title or Publisher to learn more.
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases
Gholami, Sepideh MD; Kemeny, Nancy E. MD; Boucher, Taryn M. BA; Gönen, Mithat PhD; Cercek, Andrea MD; Kingham, T. Peter MD; Balachandran, Vinod MD; Allen, Peter MD; DeMatteo, Ronald MD; Drebin, Jeffrey MD, PhD; Jarnagin, William MD; D’Angelica, Michael MD, FACS
Annals of Surgery – August 2020
Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands
Florian E. Buisman MD, Dirk J. Grünhagen MD, PhD, Marjolein Y. V. Homs MD, PhD, Cecile Grootscholten MD, PhD, Wills F. Filipe MD, Nancy E. Kemeny MD, Andrea Cercek MD, Micheal I. D’Angelica MD, Maarten L. Donswijk MD, Leni van Doorn NP, Jasper Emmering MD, PhD, William R. Jarnagin MD, T. Peter Kingham MD, Elisabeth G. Klompenhouwer MD, PhD, Niels F. M. Kok MD, PhD, Maria C. Kuiper NP, Adriaan Moelker MD, PhD, Warner Prevoo MD, Michelle W. J. Versleijen MD, PhD, Cornelis Verhoef MD, PhD, Koert F. D. Kuhlmann MD, PhD & Bas Groot Koerkamp MD, PhD
Updated long‐term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy
Nancy E. Kemeny MD.,Joanne F. Chou MPH,Taryn M. Boucher BA, Marinela Capanu PhD., Ronald P. DeMatteo MD., William R. Jarnagin MD., Peter J. Allen MD., Yuman C. Fong MD., Andrea Cercek MD., Michael I. D'Angelica MD.
Wiley Online Library – February 2016
The re-birth of hepatic arterial infusion for colorectal liver metastases
J Gastrointest Oncol, Nancy E Kemeny
Phase I trial of adjuvant hepatic arterial infusion (HAI)with floxuridine (FUDR) and dexamethasone plussystemic oxaliplatin, 5-fluorouracil and leucovorin inpatients with resected liver metastases from colorectal cancer
N. Kemeny, M. Capanu, M. D’Angelica, W. Jarnagin, D. Haviland, R. Dematteo & Y. Fong
European Society for Medical Oncology – December 2008